Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.
Recruiting
N/A
Interventional Study
All Types of Metastatic Solid Malignancy
1st-line Treatment
Exome Analysis
Active File EXOMA2 Study
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 80 (estimated)
- Sponsor
- Centre Georges Francois Leclerc · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Currently, the EXOMA2 study (NCT04614480) offers earlier and more comprehensive exome analysis in the management of cancer patients than EXOMA. Based on the active EXOMA2 patient file, the INFOGene study offers the opportunity to study patient-physician communication, to assess patient preferences with regard to different information modalities concerning theranostic exome analysis, and to reflect…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient identified for inclusion in the EXOMA 2 study (exome analysis request)
* Available to receive different types of information
* Fluent in French
* No prior oncogenetic consultation
* Having been informed of the objectives of the study and having given written non-object…
Contacts
No contact information available.